These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

809 related items for PubMed ID: 12237787

  • 21. Outcome in delusional depression comparing trimipramine monotherapy with a combination of amitriptyline and haloperidol--a double-blind multicenter trial.
    Künzel HE, Ackl N, Hatzinger M, Held K, Holsboer-Trachsler E, Ising M, Kaschka W, Kasper S, Konstantinidis A, Sonntag A, Uhr M, Yassouridis A, Holsboer F, Steiger A.
    J Psychiatr Res; 2009 Apr; 43(7):702-10. PubMed ID: 19038406
    [Abstract] [Full Text] [Related]

  • 22. Effect of zolpidem on sleep architecture and its next-morning residual effect in insomniac patients: a randomized crossover comparative study with brotizolam.
    Uchimura N, Nakajima T, Hayash K, Nose I, Hashizume Y, Ohyama T, Habukawa M, Kotorii N, Kuwahara H, Maeda H.
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jan; 30(1):22-9. PubMed ID: 16048734
    [Abstract] [Full Text] [Related]

  • 23. Nocturnal melatonin secretion and sleep after doxepin administration in chronic primary insomnia.
    Hajak G, Rodenbeck A, Adler L, Huether G, Bandelow B, Herrendorf G, Staedt J, Rüther E.
    Pharmacopsychiatry; 1996 Sep; 29(5):187-92. PubMed ID: 8895944
    [Abstract] [Full Text] [Related]

  • 24. Cognitive behavior therapy and pharmacotherapy for insomnia: a randomized controlled trial and direct comparison.
    Jacobs GD, Pace-Schott EF, Stickgold R, Otto MW.
    Arch Intern Med; 2004 Sep 27; 164(17):1888-96. PubMed ID: 15451764
    [Abstract] [Full Text] [Related]

  • 25. The partial positive allosteric GABA(A) receptor modulator EVT 201 is efficacious and safe in the treatment of adult primary insomnia patients.
    Walsh JK, Thacker S, Knowles LJ, Tasker T, Hunneyball IM.
    Sleep Med; 2009 Sep 27; 10(8):859-64. PubMed ID: 19345644
    [Abstract] [Full Text] [Related]

  • 26. Zolpidem and rebound insomnia--a double-blind, controlled polysomnographic study in chronic insomniac patients.
    Monti JM, Attali P, Monti D, Zipfel A, de la Giclais B, Morselli PL.
    Pharmacopsychiatry; 1994 Jul 27; 27(4):166-75. PubMed ID: 7972349
    [Abstract] [Full Text] [Related]

  • 27. Quetiapine for primary insomnia: a double blind, randomized controlled trial.
    Tassniyom K, Paholpak S, Tassniyom S, Kiewyoo J.
    J Med Assoc Thai; 2010 Jun 27; 93(6):729-34. PubMed ID: 20572379
    [Abstract] [Full Text] [Related]

  • 28. Increased deep sleep after trazodone use: a double-blind placebo-controlled study in healthy young adults.
    Ware JC, Pittard JT.
    J Clin Psychiatry; 1990 Sep 27; 51 Suppl():18-22. PubMed ID: 2211560
    [Abstract] [Full Text] [Related]

  • 29. Tricyclic antidepressants in the treatment of insomnia.
    Ware JC.
    J Clin Psychiatry; 1983 Sep 27; 44(9 Pt 2):25-8. PubMed ID: 6355074
    [Abstract] [Full Text] [Related]

  • 30. Tiagabine enhances slow wave sleep and sleep maintenance in primary insomnia.
    Walsh JK, Zammit G, Schweitzer PK, Ondrasik J, Roth T.
    Sleep Med; 2006 Mar 27; 7(2):155-61. PubMed ID: 16260179
    [Abstract] [Full Text] [Related]

  • 31. Quetiapine improves visual hallucinations in Parkinson disease but not through normalization of sleep architecture: results from a double-blind clinical-polysomnography study.
    Fernandez HH, Okun MS, Rodriguez RL, Malaty IA, Romrell J, Sun A, Wu SS, Pillarisetty S, Nyathappa A, Eisenschenk S.
    Int J Neurosci; 2009 Mar 27; 119(12):2196-205. PubMed ID: 19916848
    [Abstract] [Full Text] [Related]

  • 32. Efficacy and tolerability of indiplon in older adults with primary insomnia.
    Walsh JK, Moscovitch A, Burke J, Farber R, Roth T.
    Sleep Med; 2007 Nov 27; 8(7-8):753-9. PubMed ID: 17825616
    [Abstract] [Full Text] [Related]

  • 33. Pilot controlled double-blind study of the hypnotic effects of zolpidem in patients with chronic 'learned' insomnia: psychometric and polysomnographic evaluation.
    Herrmann WM, Kubicki ST, Boden S, Eich FX, Attali P, Coquelin JP.
    J Int Med Res; 1993 Nov 27; 21(6):306-22. PubMed ID: 8143886
    [Abstract] [Full Text] [Related]

  • 34. Lormetazepam - a benzodiazepine derivative without hangover effect? A double-blind study with chronic insomniacs in a general practice setting.
    Heidrich H, Ott H, Beach RC.
    Int J Clin Pharmacol Ther Toxicol; 1981 Jan 27; 19(1):11-7. PubMed ID: 6110634
    [Abstract] [Full Text] [Related]

  • 35. Sleep laboratory study of lormetazepam in older insomniacs.
    Vogel GW.
    Psychopharmacology Suppl; 1984 Jan 27; 1():69-78. PubMed ID: 6147842
    [Abstract] [Full Text] [Related]

  • 36. An evaluation of the efficacy and safety of eszopiclone over 12 months in patients with chronic primary insomnia.
    Roth T, Walsh JK, Krystal A, Wessel T, Roehrs TA.
    Sleep Med; 2005 Nov 27; 6(6):487-95. PubMed ID: 16230048
    [Abstract] [Full Text] [Related]

  • 37. Effect of zolpidem on sleep in women with perimenopausal and postmenopausal insomnia: a 4-week, randomized, multicenter, double-blind, placebo-controlled study.
    Dorsey CM, Lee KA, Scharf MB.
    Clin Ther; 2004 Oct 27; 26(10):1578-86. PubMed ID: 15598474
    [Abstract] [Full Text] [Related]

  • 38. Tiagabine increases slow-wave sleep in a dose-dependent fashion without affecting traditional efficacy measures in adults with primary insomnia.
    Walsh JK, Perlis M, Rosenthal M, Krystal A, Jiang J, Roth T.
    J Clin Sleep Med; 2006 Jan 15; 2(1):35-41. PubMed ID: 17557435
    [Abstract] [Full Text] [Related]

  • 39. Doxepin in the treatment of primary insomnia: a placebo-controlled, double-blind, polysomnographic study.
    Hajak G, Rodenbeck A, Voderholzer U, Riemann D, Cohrs S, Hohagen F, Berger M, Rüther E.
    J Clin Psychiatry; 2001 Jun 15; 62(6):453-63. PubMed ID: 11465523
    [Abstract] [Full Text] [Related]

  • 40. Zolpidem is not superior to temazepam with respect to rebound insomnia: a controlled study.
    Voshaar RC, van Balkom AJ, Zitman FG.
    Eur Neuropsychopharmacol; 2004 Aug 15; 14(4):301-6. PubMed ID: 15163440
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 41.